Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Wantong Pharmaceutical Group Meihe Pharmaceutical is a prominent subsidiary of the Jilin Wantong Pharmaceutical Group, based in Meihekou, Jilin Province, China. The company focuses on the production and distribution of Traditional Chinese Medicines (TCM) and chemical drugs across multiple therapeutic categories, including cardiovascular, gastrointestinal, and respiratory health. It operates large-scale, GMP-certified manufacturing facilities capable of producing various formulations such as tablets, capsules, and granules. The company is a vital component of the Wantong Group's supply chain, contributing to its reputation as a leading pharmaceutical brand in Northeast China. Its product line includes well-known domestic brands for treating common ailments like stomach pain, coughs, and joint inflammation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Wantong Pharmaceutical Group Meihe Pharmaceutical.